Preview

Russian Pediatric Journal

Advanced search

Myocarditis in children. Modern aspects of diagnostics

https://doi.org/10.46563/1560-9561-2024-27-5-385-393

EDN: smbpcr

Abstract

Introduction. A review of the current literature on the features of the diagnosis of myocarditis in children is presented. Myocarditis is an acute or chronic inflammatory myocardial disease characterized by a variety of clinical manifestations, nonspecific symptoms and physical data. With insufficient number of informative diagnostic tests, there is a challenge for practitioners at all stages of medical care. Aim of the review is to comprehensively present the features of the clinical diagnosis of myocarditis in children. The presence of myocarditis should be assumed in situations where children, regardless of the age, first developed symptoms of heart failure (HF), as well as in the presence of a clinic of viral infections accompanied by respiratory or abdominal symptoms, combined with the development of tachycardia, hypotension or cardiac arrhythmias, even in the absence of cardiomegaly. Myocarditis should be clinically suspected at the stage when the necessary decisions should be made about the patient’s routing, the formation of a complex of diagnostic examinations and the start of therapy. Magnetic resonance imaging (MRI) of the heart is today the non-invasive gold standard for the diagnosis of myocarditis that allows detecting myocarditis within 2–3 weeks after the first symptoms appear. Endomyocardial biopsy can be used for accurate morphological diagnosis of myocarditis in children. Molecular biological and genetic studies that determine the severity and outcome of the disease are important for the diagnosis of myocarditis in children.

Conclusion. Based on the literature data and own experience in diagnosing myocarditis, the authors have developed an original diagnostic algorithm to make the right medical decision in case of suspected acute myocarditis in children.

Contribution:
Vasichkina E.S. — concept and design of the study;
Vasichkina E.S., Balykova L.A., Basargina E.N., Bregel L.V., Degtyareva E.A., Kovalev I.A., Kotlukova N.P., Leontyeva I.V., Yakovleva L.V., Groznova O.S. — collection and processing of material;
Vasichkina E.S., Kovalev I.A., Kotlukova N.P., Leontyeva I.V. — writing the text;
Balykova L.A., Basargina E.N., Bregel L.V., Degtyareva E.A., Yakovleva L.V., Groznova O.S. — editing the text.
All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.

Acknowledgment. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Received: September 12, 2024
Accepted: October 08, 2024
Published: November 12, 2024

About the Authors

Elena S. Vasichkina
National Medical Research Center named after V.A. Almazov
Russian Federation

MD, PhD, DSc, Head, Research Center for Unknown, Rare and Genetically Caused Diseases, prof. of the Department of children’s diseases, National Medical Research Center named after V.A. Almazov

e-mail: vasichkinalena@mail.ru



Larisa A. Balykova
National Research Mordovian State University named after N.P. Ogarev
Russian Federation


Elena N. Basargina
National Medical Research Center for Children’s Health
Russian Federation


Lyudmila V. Bregel
Irkutsk State Medical Academy of Postgraduate Education — branch of the Russian Medical Academy of Continuous Professional Education
Russian Federation


Elena A. Degtyareva
Russian University of People Friendship
Russian Federation


Igor A. Kovalev
N.I. Pirogov Russian National Research Medical University
Russian Federation


Nataliya P. Kotlukova
N.I. Pirogov Russian National Research Medical University
Russian Federation


Irina V. Leontyeva
N.I. Pirogov Russian National Research Medical University
Russian Federation


Lyudmila V. Yakovleva
Bashkir State Medical University
Russian Federation


Olga S. Groznova
N.I. Pirogov Russian National Research Medical University; Charity Fund for Medical and Social Genetic Assistance Projects «Genome of Life»
Russian Federation


References

1. Rodriguez-Gonzalez M., Sanchez-Codez M.I., Lubian-Gutierrez M., Castellano-Martinez A. Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: A retrospective study. World J. Clin. Cases. 2019; 7(5): 548–61. https://doi.org/10.12998/wjcc.v7.i5.548

2. Schubert S., Opgen-Rhein B., Boehne M., Weigelt A., Wagner R., Müller G., et al. MYKKE consortium. Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: Results from the prospective multicenter registry “MYKKE”. Pediatr. Transplant. 2019; 23(7): e13548. https://doi.org/10.1111/petr.13548

3. Howard А., Hasan A., Brownlee J., Mehmood N., Ali M., Mehta S., et al. Pediatric myocarditis protocol: an algorithm for early identification and management with retrospective analysis for validation. Pediatr. Cardiol. 2020; 41(2): 316–26. https://doi.org/10.1007/s00246-019-02258-1

4. Kantor P.F., Lougheed J., Dancea A., McGillion M., Barbosa N., Chan C., et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines. Can. J. Cardiol. 2013; 29(12): 1535–52. https://doi.org/10.1016/j.cjca.2013.08.008

5. Dasgupta S., Iannucci G., Mao C., Clabby M., Oster M.E. Myocarditis in the pediatric population: A review. Congenit. Heart Dis. 2019; 14(5): 868–77. https://doi.org/10.1111/chd.12835

6. Canter C.E., Simpson K.P. Diagnosis and treatment of myocarditis in children in the current era. Circulation. 2014; 129(1): 115–28. https://doi.org/10.1161/circulationaha.113.001372

7. Bejiqi R., Retkoceri R., Maloku A., Mustafa A., Bejiqi H., Bejiqi R. The diagnostic and clinical approach to pediatric myocarditis: a review of the current literature. Open Access Maced. J. Med. Sci. 2019; 7(1): 162–73. https://doi.org/10.3889/oamjms.2019.010

8. Baggio С., Gagno G., Porcari A., Paldino A., Artico J., Castrichini M., et al. Myocarditis: which role for genetics? Curr. Cardiol. Rep. 2021; 23(6): 58–63. https://doi.org/10.1007/s11886-021-01492-5

9. Durani Y., Giordano K., Goudie B.W. Myocarditis and pericarditis in children. Pediatr. Clin. North Am. 2010; 57(6): 1281–303. https://doi.org/10.1016/j.pcl.2010.09.012

10. Bergmann K.R., Kharbanda A., Haveman L. Myocarditis and pericarditis in the pediatric patient: validated management strategies. Pediatr. Emerg. Med. Pract. 2015; 12(7): 1–22; quiz 23.

11. Kern J., Modi R., Atalay M.K., Kochilas L.K. Clinical myocarditis masquerading as acute coronary syndrome. J. Pediatr. 2009; 154(4): 612–5. https://doi.org/10.1016/j.jpeds.2008.10.018

12. Tunuguntla H., Jeewa A., Denfield S.W. Acute myocarditis and pericarditis in children. Pediatr. Rev. 2019; 40(1): 14–25. https://doi.org/10.1542/pir.2018-0044

13. Cooper L.T. Jr. Ventricular arrhythmias and sudden cardiac death in lymphocytic myocarditis. J. Am. Coll. Cardiol. 2020: 75(9): 1058–60. https://doi.org/10.1016/j.jacc.2020.01.032

14. Ling N., Li C.L., Wang Z.Z., Zhang H.N., Xu H., An X.J. Heart rate variability in children with myocarditis presenting with ventricular arrhythmias. Eur. Rev. Med. Pharmacol. Sci. 2018; 22(4): 1102–5. https://doi.org/10.26355/eurrev_201802_14397

15. Shkolnikova M.A., Alekseeva E.I. Clinical Recommendations for Pediatric Cardiology and Rheumatology [Klinicheskie rekomendatsii po detskoy kardiologii i revmatologii]. Moscow; 2011. https://elibrary.ru/tjeiil (in Russian)

16. Brady W.J., Ferguson J.D., Ullman E.A., Perron A.D. Myocarditis: emergency department recognition and management. Emerg. Med. Clin. North Am. 2004; 22(4): 865–85. https://doi.org/10.1016/j.emc.2004.05.010

17. Balykova L.A., Krasnopolskaya A.V., Vlasova E.A. Myocarditis in children: clinical overview, diagnosis and treatment. Pediatricheskaya farmakologiya. 2020; 17(2): 137–47. https://doi.org/10.15690/pf.v17i2.2100 https://elibrary.ru/yrbicz

18. Patel M.S., Berg A.M., Vincent R.N., Mahle W.T. Serum parameters and echocardiographic predictors of death or need for transplant in newborns, children, and young adults with heart failure. Am. J. Cardiol. 2010; 105(12): 1798–801. https://doi.org/10.1016/j.amjcard.2010.01.357

19. Caforio A.L., Pankuweit S., Arbustini E., Basso C., Gimeno-Blanes J., Felix S.B., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis. Eur. Heart J. 2013; 34(33): 2636–48. https://doi.org/10.1093/eurheartj/eht210

20. Brambatti M., Matassini M.V., Adler E.D., Klingel K., Camici P.G., Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J. Am. Coll. Cardiol. 2017; 70(19): 2363–75. https://doi.org/10.1016/j.jacc.2017.09.023

21. Lippi G., Salvagno G.L., Guidi G.C. Cardiac troponins in pediatric myocarditis. Pediatrics. 2008; 121(4): 864. https://doi.org/10.1542/peds.2008-0031

22. Abe T., Tsuda E., Miyazaki A., Ishibashi-Ueda H., Yamada O. Clinical characteristics and long-term outcome of acute myocarditis in children. Heart Vessels. 2013; 28(5): 632–8. https://doi.org/10.1007/s00380-012-0296-8

23. Putschoegl A., Auerbach S. Diagnosis, evaluation, and treatment of myocarditis in children. Pediatr. Clin. N. Am. 2020; 67(5): 855–74. https://doi.org/10.1016/j.pcl.2020.06.013

24. Kühl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. 2005; 111(7): 887–93. https://doi.org/10.1161/01.CIR.0000155616.07901.35

25. Masarone D., Valente F., Rubino M., Vastarella R., Gravino R., Rea A. Pediatric heart failure: a practical guide to diagnosis and management. Pediatr. Neonatol. 2017; 58(4): 303–12. https://doi.org/10.1016/j.pedneo.2017.01.001

26. Kirk R., Dipchand A.I., Rosenthal D.N., Addonizio L., Burch M., Chrisant M., et al. Guidelines for the management of pediatric heart failure: Executive summary. J. Heart Lung. Transplant. 2014; 33(9): 888–909. https://doi.org/10.1016/j.healun.2014.06.002

27. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ. J. Off. J. Jpn Circ. Soc. 2011; 75(3): 734–43. https://doi.org/10.1253/circj.cj-88-0008

28. McNamara D.M. Heart Failure as a Consequence of Viral and Nonviral Myocarditis Heart Failure: A Companion to Braunwald’s Heart Disease. Elsevier; 2020: 376–84.

29. Vigneswaran T.V., Brown J.R., Breuer J., Burch M. Parvovirus B19 myocarditis in children: an observational study. Arch. Dis. Child. 2016; 101(2): 177–80. https://doi.org/10.1136/archdischild-2014-308080

30. Suthar D., Dodd D.A., Godown J. Identifying non-invasive tools to distinguish acute myocarditis from dilated cardiomyopathy in children. Pediatr. Cardiol. 2018; 39(6): 1134–8. https://doi.org/10.1007/s00246-018-1867-y

31. Sagar S., Liu P.P., Cooper L.T. Jr. Myocarditis. Lancet. 2012; 379(9817): 738–47. https://doi.org/10.1016/S0140-6736(11)60648-X

32. Foerster S.R., Canter C.E., Cinar A., Sleeper L.A., Webber S.A., Pahl E., et al Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood. Circ. Heart Fail. 2010; 3(6): 689–97. https://doi.org/10.1161/Circheartfailure.109.902833

33. Felker G.M., Boehmer J.P., Hruban R.H., Hutchins G.M., Kasper E.K., Baughman K.L., et al Echocardiographic findings in fulminant and acute myocarditis. J. Am. Coll. Cardiol. 2000; 36(1): 227–32. https://doi.org/10.1016/s0735-1097(00)00690-2

34. Gursu H.A., Cetin A.E., Azak E., Kibar A.E., Surucu M., Orgun A., et al. The assessment of treatment outcomes in patients with acute viral myocarditis by speckle tracking and tissue Doppler methods. Echocardiography. 2019; 36: 1666–74. https://doi.org/10.1111/echo.14449

35. Rroku A., Kottwitz J., Heidecker B. Update on myocarditis – what we know so far and where we may be heading. Eur. Heart J. Acute Cardiovasc. Care. 2021; 10(4): 455–47. https://doi.org/10.1177/2048872620910109

36. Wisotzkey B.L., Soriano B.D., Albers E.L., Ferguson M., Buddhe S. Diagnostic role of strain imaging in atypical myocarditis by echocardiography and cardiac MRI. Pediatr. Radiol. 2018; 48(6): 835–42. https://doi.org/10.1007/s00247-017-4061-0

37. Khoo N.S., Smallhorn J.F., Atallah J., Kaneko S., Mackie A.S., Paterson I. Altered left ventricular tissue velocities, deformation and twist in children and young adults with acute myocarditis and normal ejection fraction. J. Am. Soc. Echocardiogr. 2012; 25(3): 294–303. https://doi.org/10.1016/j.echo.2011.10.010

38. Banka P., Robinson J.D., Uppu S.C., Harris M.A., Hasbani K., Lai W.W., et al. Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study. J. Cardiovasc. Magn. Reson. 2015; 17: 96. https://doi.org/10.1186/s12968-015-0201-6

39. Friedrich M.G., Sechtem U., Schulz-Menger J., Holmvang G., Alakija P., Cooper L.T., et al. International consensus group on cardiovascular magnetic resonance in myocarditis. Cardiovascular magnetic resonance in myocarditis. J. Am. Coll. Cardiol. 2009; 53(17): 1475–87. https://doi.org/10.1016/j.jacc.2009.02.007

40. Pan J.A., Lee Y.J., Salerno M. Diagnostic performance of extracellular volume, native T1, and T2 mapping versus Lake Louise criteria by cardiac magnetic resonance for detection of acute myocarditis: a meta-analysis. Circ. Cardiovasc. Imaging. 2018; 11(7): e007598. https://doi.org/10.1161/Circimaging.118.007598

41. Ferreira V.M., Schulz-Menger J., Holmvang G., Kramer C.M., Carbone I., Sechtem U., et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J. Am. Coll. Cardiol. 2018; 72(24): 3158–76. https://doi.org/10.1016/j.jacc.2018.09.072

42. Messroghli D.R., Moon J.C., Ferreira V.M., Grosse-Wortmann L., He T., Kellman P., et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume. J. Cardiovasc. Magn. Reson. 2017; 19(1): 75. https://doi.org/10.1186/s12968-017-0389-8

43. Lv J., Han B., Wang C., Wang J., Jiang D., Zhao L., et al. The clinical features of children with acute fulminant myocarditis and the diagnostic and follow-up value of cardiovascular magnetic resonance. Front. Pediatr. 2019; 7: 388. https://doi.org/10.3389/fped.2019.00388

44. Luetkens J.A., Faron A., Isaak A., Dabir D., Kuetting D., Feisst A., et al. Comparison of original and 2018 Lake Louise criteria for diagnosis of acute myocarditis: results of a validation cohort. Radiol. Cardiothorac. Imaging. 2019; 1(3): e190010. https://doi.org/10.1148/ryct.2019190010

45. Malek L.A., Kamińska H., Barczuk-Falęcka M., Ferreira V.M., Wójcicka J., Brzewski M., et al. Children with acute myocarditis often have persistent subclinical changes as revealed by cardiac magnetic resonance. J. Magn. Reson. Imaging. 2020; 52(2): 488–96. https://doi.org/10.1002/jmri.27036

46. Aquaro G.D., Ghebru Habtemicael Y., Camastra G., Monti L., Dellegrottaglie S., Moro C., et al. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis. J. Am. Coll. Cardiol. 2019; 74(20): 2439–48. https://doi.org/10.1016/j.jacc.2019.08.1061

47. Berg J., Kottwitz J., Baltensperger N., Kissel C.K., Lovrinovic M., Mehra T., et al. Cardiac magnetic resonance imaging in myocarditis reveals persistent disease activity despite normalization of cardiac enzymes and inflammatory parameters at 3-month follow-up. Circ. Heart. 2017; 10(11): e004262. https://doi.org/10.1161/Circheartfailure.117.004262

48. Degener F., Opgen-Rhein B., Böhne M., Weigelt A., Wagner R., Müller G.C., et al. Four-year experience of the German multicenter registry for pediatric patients with suspected myocarditis: MYKKE. Thorac. Cardiovasc. Surg. 2018; 66(S02): S111–38. https://doi.org/10.1055/s-0038-1628324

49. Bussani R., Silvestri F., Perkan A., Gentile P., Sinagra G., Merlo M., et al. Endomyocardial Biopsy. 2019. In: Sinagra G., Merlo M., Pinamonti B., eds. Dilated Cardiomyopathy: from Genetics to Clinical Management. Cham: Springer; 2019.

50. Katzmann J.L., Schlattmann P., Rigopoulos A.G., Noutsias E., Bigalke B., Pauschinger M., et al. Meta-analysis on the immunohistological detection of inflammatory cardiomyopathy in endomyocardial biopsies. Heart Fail. Rev. 2020; 25(2): 277–94. https://doi.org/10.1007/s10741-019-09835-9

51. Cooper L.T., Baughman K.L., Feldman A.M., Frustaci A., Jessup M., Kuhl U., et al. The role of endomyocardial biopsy in the management of cardiovascular disease. J. Am. Coll. Cardiol. 2007; 50(19): 1914–31. https://doi.org/10.1016/j.jacc.2007.09.008

52. Bowles N.E., Ni J., Kearney D.L., Pauschingeret M., Schultheiss H.P., McCarthy R., et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 2003; 42(3): 466–72. https://doi.org/10.1016/s0735-1097(03)00648-x

53. Freedman S.B., Haladyn J.K., Floh A., Kirsh J.A., Taylor G., Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007; 120(6): 1278–85. https://doi.org/10.1542/peds.2007-1073


Review

For citations:


Vasichkina E.S., Balykova L.A., Basargina E.N., Bregel L.V., Degtyareva E.A., Kovalev I.A., Kotlukova N.P., Leontyeva I.V., Yakovleva L.V., Groznova O.S. Myocarditis in children. Modern aspects of diagnostics. Russian Pediatric Journal. 2024;27(5):385-393. (In Russ.) https://doi.org/10.46563/1560-9561-2024-27-5-385-393. EDN: smbpcr

Views: 125


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-9561 (Print)
ISSN 2413-2918 (Online)